Johnson & Johnson found that 10% to 15% of AI use cases deliver 80% of the value.The company is focusing on the highest-value projects and cutting the rest.The use cases delivering the most value include a generative AI copilot and an internal chatbot.Johnson & Johnson is also developing AI tools for drug discovery and supply chain risk mitigation.